CorMedix Ownership | Who Owns CorMedix?


OverviewForecastRevenueFinancialsChartTranscripts

CorMedix Ownership Summary


CorMedix is owned by 50.26% institutional investors, 7.30% insiders, and 42.44% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.89% of CRMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.14% of its assets in CorMedix shares.

CRMD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCorMedix50.26%7.30%42.44%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.36M7.89%$66.03M
Blackrock3.55M6.18%$15.39M
Vanguard group3.38M5.74%$27.36M
Marshall wace, llp2.58M3.80%$31.79M
Nomura1.42M2.47%$6.16M
State street1.45M2.47%$11.77M
Geode capital management1.39M2.37%$11.28M
Ghisallo capital management750.00K1.10%$9.24M
Alyeska investment group750.00K1.10%$9.24M
Anson funds management lp725.00K1.07%$8.93M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Spinnaker capital175.38K100.00%$1.42M
Palisades investment partners562.53K3.03%$6.93M
Anson funds management lp725.00K1.29%$8.93M
Wingate wealth advisors129.54K1.04%$1.51M
Militia capital partners, lp100.00K0.57%$1.23M
Planning directions50.00K0.35%$616.00K
Adar1 capital management175.00K0.33%$2.16M
Oberweis asset management inc/485.00K0.26%$5.98M
Ghisallo capital management750.00K0.25%$9.24M
Entrypoint capital36.66K0.23%$451.71K

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp2.58M0.04%2.35M
Alyeska investment group750.00K0.03%750.00K
Ghisallo capital management750.00K0.25%750.00K
Anson funds management lp725.00K1.29%725.00K
Blackrock funding, inc. /de5.36M0.00%633.85K

Top Sellers

HolderShares% AssetsChange
Elliott investment management---2.44M
Nomura1.42M0.01%-1.53M
Rosalind advisors---1.48M
First turn management---1.02M
J. goldman & co lp---457.32K

New Positions

HolderShares% AssetsChangeValue
Ghisallo capital management750.00K0.25%750.00K$9.24M
Alyeska investment group750.00K0.03%750.00K$9.24M
Anson funds management lp725.00K1.29%725.00K$8.93M
Driehaus capital management307.24K0.03%307.24K$3.79M
Portolan capital management283.66K0.22%283.66K$3.49M

Sold Out

HolderChange
National bank of canada /fi/-2.00
Ifp advisors-5.00
Nelson, van denburg & campbell wealth management group-11.00
Srs capital advisors-31.00
Capital performance advisors llp-47.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202517521.53%34,137,26843.81%503.80%11247.37%34-5.56%
Mar 31, 20251435.15%23,487,0182.32%352.36%75-17.58%3663.64%
Dec 31, 202413424.07%22,609,36218.08%383.63%8953.45%21-
Sep 30, 20241073.88%19,101,28511.30%323.65%587.41%20-9.09%
Jun 30, 20241038.42%17,161,283-0.70%293.20%5474.19%22-35.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.34M3.14%-51.92K
Vanguard US Total Market Shares ETF1.73M2.66%-
iShares Russell 2000 ETF1.56M2.09%-
Fidelity Small Cap Growth1.16M1.70%-
Vanguard Institutional Extnd Mkt Idx Tr730.98K0.98%-320.99K
Fidelity Small Cap Index644.95K0.86%29.61K
Fidelity Small Cap Growth K6533.26K0.79%-
Nuveen Quant Small Cap Equity R6580.52K0.78%-
iShares Russell 2000 Growth ETF571.19K0.77%-
Voya Small Cap Growth (Portland)409.32K0.67%409.32K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 23, 2025Kaplan Myron-Buy$275.50K
Sep 12, 2025DUNTON ALAN W-Sell$131.30K
Sep 12, 2025Todisco Joseph Chief Executive OfficerSell$650.00K
Sep 09, 2025Zelnick Kaufman Beth Chief Legal OfficerSell$665.14K
Sep 09, 2025Zelnick Kaufman Beth Chief Legal OfficerSell$5.13K

Insider Transactions Trends


DateBuySell
2025 Q3-5
2025 Q2--
2025 Q1--
2024 Q411
2024 Q2--

CRMD Ownership FAQ


Who Owns CorMedix?

CorMedix shareholders are primarily institutional investors at 50.26%, followed by 7.30% insiders and 42.44% retail investors. The average institutional ownership in CorMedix's industry, Biotech Stocks , is 307.10%, which CorMedix falls below.

Who owns the most shares of CorMedix?

CorMedix’s largest shareholders are Blackrock funding, inc. /de (5.36M shares, 7.89%), Blackrock (3.55M shares, 6.18%), and Vanguard group (3.38M shares, 5.74%). Together, they hold 19.81% of CorMedix’s total shares outstanding.

Does Blackrock own CorMedix?

Yes, BlackRock owns 6.18% of CorMedix, totaling 3.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.39M$. In the last quarter, BlackRock increased its holdings by 66.48K shares, a 1.91% change.

Who is CorMedix’s biggest shareholder by percentage of total assets invested?

Spinnaker capital is CorMedix’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 175.38K CorMedix shares, valued at 1.42M$.

Who is the top mutual fund holder of CorMedix shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of CorMedix shares, with 3.14% of its total shares outstanding invested in 2.34M CorMedix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools